Neuroligin 3 Perturbation Converges on an Extracellular Adhesion Program Across Glioma and Human Astroglia
Neuroligin 3 (NLGN3) sits at an awkward intersection: it is an autism-linked synaptic adhesion molecule, a shed glioma mitogen, and an astroglial perturbation whose transcriptional consequences are still being defined. We asked whether these disease contexts share a measurable NLGN3-responsive transcriptional axis. We reanalyzed two public human RNA-seq datasets: recombinant NLGN3 exposure in SU-pcGBM2 high-grade glioma cultures (GSE99045) and NLGN3 R451C knock-in astroglia-enriched organoids versus isogenic 3D wild type (GSE283484). Because the glioma dataset provides FPKM rather than raw counts, we used effect-size and rank-based convergence rather than count-model differential expression. Global transcriptome concordance was weak (Spearman rho = 0.014, p = 0.109 across 12,598 matched expressed genes), but genes with moderate effects in both systems were same-direction more often than expected (905/1,677, binomial p = 6.3e-4). Top upregulated genes showed strong same-direction overlap: the top 1,000 induced genes overlapped by 198 genes versus 79 expected (odds ratio = 3.32, Fisher p = 2.45e-36). Curated module analysis identified extracellular matrix and adhesion genes as the clearest shared signal (mean log2 fold-change +0.15 in glioma and +1.80 in astroglia; empirical product FDR = 0.0064), not canonical neurexin-neuroligin synaptic genes. These results argue that cross-context NLGN3 biology is not a generic synaptic transcriptome program. It is a focused adhesion-remodeling response that appears in both glioma exposure and mutant human astroglia.
Reviews
This study reanalyzes two public human RNA-seq datasets to ask whether NLGN3 perturbations in very different contexts (recombinant NLGN3 exposure in a patient-derived glioma culture vs. an autism-linked NLGN3 R451C knock-in in astroglia-enriched organoids) converge on a shared transcriptional axis. The paper is appropriately cautious about weak genome-wide concordance (near-zero Spearman correlation) and instead focuses on enrichment-style signals: an excess of same-direction changes among moderately affected genes, and a strong overlap among the top induced genes, with a curated extracellular matrix/adhesion module emerging as the most coherent shared component. The main uncertainty is whether the reported convergence reflects a specific NLGN3-driven program or generic stress/state differences amplified by (i) using FPKM/TPM-derived fold-changes without a count-based error model, (ii) very small n (2 vs 2 in GSE99045), (iii) heterogeneous perturbations (acute ligand exposure vs constitutive knock-in) and cell systems (glioma line vs organoids), and (iv) potential confounding from baseline differences in cell composition or maturation in organoids. The very small effect size reported for the ECM/adhesion module in glioma (mean log2FC +0.15) raises questions about robustness to gene filtering, batch effects, and ranking ties; nevertheless, the conclusion is framed narrowly (focused adhesion-remodeling rather than global synaptic program), which is mostly justified by the presented enrichment statistics, assuming the analysis is not driven by unmodeled technical variance.